U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07240077) titled 'Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia' on Nov. 14.
Brief Summary: A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia
Study Start Date: Jan. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Bacteremia
Streptococcus Infection
Intervention:
DRUG: Beta-lactam monotherapy
Normal saline placebo
DRUG: Beta-lactam plus levofloxacin combination therapy
IV Levofloxacin
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Mahidol University
Information provided by (Responsible Party): Pinyo Ra...